Sanofi India share price gained up to 6% in morning trades on Friday post Q4 results announced by the company after the ...
Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...
With a market valuation of Rs 11,574.76 Cr, Sanofi Indias shares ended Fridays trading session on the BSE 0.58% higher at Rs ...
Novavax Inc (NVAX) outlines its strategic focus on partnerships and pipeline expansion while navigating revenue fluctuations ...
14h
Hosted on MSNNovavax Lands Wall Street 'Buy' Rating After Q4 Results, Retail Bulls Eye More Upside On Sanofi PartnershipNovavax Inc. (NVAX) shares climbed over 1% in after-hours trading Thursday as the vaccine maker's revenue outlook and ...
Sanofi Indias standalone net profit jumped 31% Rs 91.3 crore in Q4 FY25 as compared with Rs 69.7 crore in Q4 FY24. Revenue increased 9.7% YoY to Rs 514.9 crore in Q4 FY25.
Kymera Therapeutics Inc (KYMR) reports robust financial health and strategic advancements, setting the stage for significant ...
After the Indian market ended the monthly expiry session on a sour tone, the early Gift Nifty trend on Friday indicated to a ...
IST, the barometer index, the S&P BSE Sensex, declined 751.63 points or 1% to 73,865. The Nifty 50 index dropped 224.55 points or 1% to 22,320.50.
Operator Good afternoon, and welcome to AbCellera's full-year 2024 business update conference call. My name is Tamia, and I will facilitate the audio portion of today's interactive broadcast.
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported a ...
22h
MarketBeat on MSNRegeneron: Is It the Perfect Biotech Stock for Value and Growth?CompanyOverview|NASDAQ:REGN] Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) stock has gone relatively unnoticed from major headlines in 2024 as GLP-1 makers like Novo Nordisk A/S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results